Why Clarity on Terminology Matters

Regulatory authorities such as the USFDA, EMA, ICH, and WHO define and apply these terms differently depending on whether the product is an API, intermediate, or finished dosage form. Using the wrong term—or placing the wrong date on a label—can result in:

• ❌ GMP observations or 483s
• ❌ Labeling recalls
• ❌ Misinterpretation of product stability and patient safety risk

Understanding these terms isn’t just academic—it’s central to regulatory compliance.

Official Definitions (ICH & WHO)

• Retest Date: The date after which a drug substance must be re-examined to verify it still meets specifications, if stored under recommended conditions (typically used for APIs).
• Expiry Date: The final date at which a drug product is expected to remain within specification and be safe and effective for use.
• Shelf Life: The total time period during which a product is expected to remain stable under specified conditions. It ends at the expiry or retest date.

These definitions are found in ICH Q1A(R2), WHO TRS 1010, and national regulatory guidelines.

Comparison Table of Key Differences

Labeling Implications and Compliance

The labeling of expiry and retest dates must comply with country-specific requirements:

• ✅ API containers must show retest date and batch number
• ✅ Finished goods must show expiry date in DD/MM/YYYY or MM/YYYY format
• ✅ Shelf life is usually included in stability data or dossier, not on physical labels

Use of incorrect date terminology on product labels has been cited in several recalls and GMP compliance observations.

Stability Testing Alignment

When generating stability data, it’s important to design studies to support each of these terms as appropriate:

• Retest Date: Include long-term and accelerated stability of APIs per ICH Q1A
• Expiry Date: Conduct full stability testing on final packaged dosage forms
• Shelf Life: Justified through trend analysis, can extend to expiry/retest date

Be cautious when converting between these terms during CTD submissions or regulatory renewals.

Where Each Term Appears in Regulatory Submissions

Common Misconceptions and Pitfalls

• ❌ Using “shelf life” on packaging instead of “expiry date”
• ❌ Applying retest dates to finished dosage forms
• ❌ Extending expiry dates without new stability data
• ❌ Ignoring regulatory variations (e.g., WHO vs ICH vs CDSCO)

Always cross-verify labeling SOPs with global dossier language and marketing country requirements.

Practical Case Scenario

A company manufacturing a bulk API labeled its material with an expiry date rather than a retest date. During a WHO PQP inspection, this was flagged as a labeling non-compliance. The company had to relabel over 40 drums of stock and update their SOPs. The issue could have been avoided by aligning their documentation with WHO’s recommendation of “retest date” for APIs.

Checklist for Teams

• ✅ Define each term clearly in SOPs and training programs
• ✅ Label APIs with retest dates and finished products with expiry dates
• ✅ Use shelf life only in internal stability and submission documents
• ✅ Align terminology in ERP, COA, and CTD
• ✅ Consult Regulatory Affairs before changing label format

For templates and SOPs, refer to SOP writing in pharma.

Conclusion

Understanding the distinctions between retest date, expiry date, and shelf life is essential for every pharmaceutical professional involved in product development, regulatory affairs, labeling, and QA. While these terms are interconnected, they are not interchangeable. Misapplication can result in regulatory action, product withdrawal, and loss of credibility.

By aligning your company’s terminology with ICH, WHO, and local guidelines—and implementing clear labeling and SOP practices—you can ensure compliance and reduce the risk of deviation or inspection findings.

References:

• ICH Q1A(R2), Q7
• WHO TRS 1010
• CDSCO Labeling Guidelines
• EMA Expiry Definitions